tracking the news, one byte at a time
Freak Pulse

Alzheimer’s Disease and Frontal Temporal Dementia this week: The NHS’s Modern Service Framework for dementia and frailty is due out this year and will be overseen by a new; and Dr Abhishek Dixit, a neurologist at Paras Health, Gurugram…

Employers are being urged to recognise the value of neurodivergent talent. Dr Faye Favill, a specialist in neurodivergent education and SENCO at St David’s College in Llandudno, will deliver the message at a business event in Wrexham on Thursday, October 1. She will speak at a Wrexham Business Professionals breakfast meeting at Hotel Wrexham on…

The Netflix series “Love on the Spectrum” won the Emmy for Outstanding Unstructured Reality Program at the Creative Arts Emmy Awards in Los Angeles, along with awards for casting and picture editing.

Researchers developed a multiancestry Alzheimer’s polygenic risk score using genetic data from European, African American, Caribbean Hispanic, and East Asian populations, then tested it across several independent and…

Neurologist Jane Alty, recruited by the University of Tasmania in 2019, observed that dementia patients in a clinic waiting room showed Parkinson’s-like movement changes, leading to a controversial theory that dementia…

Autism and ADHD Services Under Strain this week: A new review by the Parliamentary and Health Service Ombudsman (PHSO) finds ADHD and autism services in England; and Advocates in Nevada are pushing for more staffing and safety measures in…

This article outlines how cognitive behavioral therapy (CBT) complements medication for ADHD across children, adolescents, and adults, citing a 2021 randomized controlled trial showing superior outcomes for combined…

Investigadores de la Universidad de California en San Francisco han trazado un mapa molecular del autismo, publicado en la revista Science, que muestra cómo mutaciones genéticas asociadas al trastorno alteran las…

A study published online Aug. 12 in Neurology examined the association between estrogen-only menopausal hormone therapy (MHT) use and Alzheimer disease (AD)-related outcomes in women aged 50 years or older from the…

FDA clears blood tests for early Alzheimer’s detection this week: The FDA has cleared for marketing PrecivityAD2, a blood test developed by C2N Diagnostics using technology invented; and The FDA has cleared for marketing PrecivityAD2, a…